You are here: Home » Reuters » News
Business Standard

Lupin expects U.S. drug pricing pressure to ease in 2019


By Zeba Siddiqui(Reuters) - India's second-largest drugmaker Lupin Ltd said on Wednesday it expected pressure on drug prices in the United States, which has hit its profits, to ease this year as larger rivals reduce their exposure there.Last week, Teva Pharmaceutical, the world's largest generic drugs maker, said it planned to cut back some of the products it sells in the U.S. market.Lupin Chief Executive Vinita Gupta said she hoped Teva's move would create space for to rival Indian drugmakers like Lupin to grow. "We do believe the worst is over," Gupta said on a post-earnings media call on ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, May 15 2018. 18:41 IST